Evidence map›Paper›PMID 34430834›Full record

ArticleEClinicalMedicine2021

Parental Bacillus Calmette-Guérin vaccine scars decrease infant mortality in the first six weeks of life: A retrospective cohort study.

Mlt Berendsen, F Schaltz-Buchholzer, P Bles, S Biering-Sørensen, K J Jensen, I Monteiro, I Silva, P Aaby, C S Benn

Open access · goldAbstract read
In one paragraph

Article in EClinicalMedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Observational
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Reimagining an immunological dogma.Nature immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Mlt BerendsenBandim Health Project, Department of Clinical Research, University of Southern Denmark and Odense University Hospital, Odense, Denmark.
F Schaltz-BuchholzerBandim Health Project, Department of Clinical Research, University of Southern Denmark and Odense University Hospital, Odense, Denmark.
P BlesBandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
S Biering-SørensenBandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
K J JensenExperimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kgs Lyngby, Denmark.
I MonteiroBandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
I SilvaBandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
P AabyBandim Health Project, Department of Clinical Research, University of Southern Denmark and Odense University Hospital, Odense, Denmark.
C S BennBandim Health Project, Department of Clinical Research, University of Southern Denmark and Odense University Hospital, Odense, Denmark.
Bandim Health Project · GWFrederiksberg Hospital · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLive attenuated vaccines have been observed to have particularly beneficial effects for child survival when given in the presence of maternally transferred immunity (priming). We aimed to test this finding and furthermore explore the role of paternal priming.

methodsIn an exploratory, retrospective cohort study in 2017, parental Bacillus Calmette-Guérin (BCG) scars were assessed for infants from the Bandim Health Project (BHP) who had participated in a 2008-2013 trial of neonatal BCG vaccination. Parental scar effects on mortality were estimated from birth to 42 days, the age of the scheduled diphtheria-tetanus-pertussis (DTP) vaccination, in Cox proportional hazard models adjusted with Inverse Probability of Treatment Weighting.

findingsFor 66% (510/772) of main trial infants that were still registered in the BHP area, at least one parent was located. BCG scar prevalence was 77% (353/461) among mothers and 63% (137/219) among fathers. In the first six weeks of life, maternal scars were associated with a mortality reduction of 60% (95%CI, 4% to 83%) and paternal scars with 49% (-68% to 84%). The maternal scar association was most beneficial among infants that had received BCG vaccination at birth (73% (-1% to 93%)). Although priming was less evident for paternal scars, having two parents with scars reduced mortality by 89% (13% to 99%) compared with either one or none of the parents having a scar.

interpretationParental BCG scars were associated with strongly increased early-life survival. These findings underline the importance of future studies into the subject of inherited non-specific immunity and parental priming.

fundingDanish National Research Foundation; European Research Council; Novo Nordisk Foundation; University of Southern Denmark.

Indexed as

Bacille Calmette-GuérinHeterologous effectsImmunological inheritanceNon-specific effects of vaccinesParental primingVertical boosting

Identifiers

PMID34430834
PMCPMC8365433
OpenAlexW3192721619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.